CD34 and acute lymphoblastic leukemia: Compared to non-ETP-ALL samples, the ETP-ALL group expressed higher levels of stem cell marker CD34 as well as myeloid markers CD11B and HLA-DRA, and lower levels of T cell commitment markers CD1A and CD8A, in this dataset (Figure 4A), concordant with the expected trends.